Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals
2022 StandoutNobel
The Changing Role of Non-Opioid Analgesic Techniques in the Management of Postoperative Pain
2005
Glutamate receptor ion channels
2005 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II
2010
Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option
2011
Risk of bleeding and antibiotic use in patients receiving continuous phenprocoumon therapy
2014
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use
2012
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype
2007 StandoutNobel
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Perioperative Management of Antithrombotic Therapy
2012 Standout
Oral Anticoagulant Therapy
2012 Standout
Cancer, Inflammation, and Therapy: Effects on Cytochrome P450–Mediated Drug Metabolism and Implications for Novel Immunotherapeutic Agents
2014
Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
2020
European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries
2010
Enantioselective Synthesis of Coumarins Catalyzed by a Bifunctional Amine–Thiourea Catalyst
2010
Pharmacogenomics of 4-Hydroxycoumarin Anticoagulants
2008
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genes
2010
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
2007
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays
2014 StandoutNobel
Dextromethorphan Mitigates Phantom Pain in Cancer Amputees
2003
Postmarketing Surveillance
2011
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
2019
Antithrombotic Therapy for VTE Disease
2012 Standout
Cannabinoid Modulation of Cutaneous Aδ Nociceptors During Inflammation
2008
The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism
2010
Computational design of an enantioselective molecular imprinted polymer for the solid phase extraction of S-warfarin from plasma
2014
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
2010 Standout
Executive Summary
2012 Standout
Status and perspectives of claims data analyses in Germany—A systematic review
2016 Standout
Treatment of patients with essential tremor
2011
Drug interactions with phenprocoumon and the risk of serious haemorrhage: a nested case–control study in a large population-based German database
2011
New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients
2014
A new high-performance liquid chromatographic method for determination of warfarin enantiomers
2005 StandoutNobel
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I
2010
Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: A review
2013 Standout
A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon
2013
A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring
2014 Standout
Pharmacologically active compounds in the environment and their chirality
2010
Future directions of stroke prevention in atrial fibrillation: the potential impact of novel anticoagulants and stroke risk stratification
2010
Design of amyloidogenic peptide traps
2024 StandoutNobel
Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemostasis
2011
Novel oral anticoagulants: clinical pharmacology, indications and practical considerations
2013
A genome-wide association study of acenocoumarol maintenance dosage
2009
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease
2011
Inflammatory Signals Enhance Piezo2-Mediated Mechanosensitive Currents
2012 StandoutNobel
Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records
2006 StandoutNobel
Review on use of German health insurance medication claims data for epidemiological research
2009
Rewarding effects of ethanol and cocaine in µ opioid receptor-deficient mice
2002
An electrochemical sensor based on multiwall carbon nanotubes and molecular imprinting strategy for warfarin recognition and determination
2014
Interventions to improve hand hygiene compliance in patient care
2017 Standout
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
The Activation of Carboxylic Acids via Self-Assembly Asymmetric Organocatalysis: A Combined Experimental and Computational Investigation
2016 StandoutNobel
Bifunctional Molecular Photoswitches Based on Overcrowded Alkenes for Dynamic Control of Catalytic Activity in Michael Addition Reactions
2016 StandoutNobel
Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon
2008
Guidelines for the Primary Prevention of Stroke
2014 Standout
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation
2016 StandoutNobel
Pharmacogenomics of CYP2C9: Functional and Clinical Considerations
2017
Applications of LC-MS to quantitation and evaluation of the environmental fate of chiral drugs and their metabolites
2008
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective
2018 Standout
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Frequency Dependence of Signal Power and Spatial Reach of the Local Field Potential
2013 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Cytochrome P4503APolymorphisms and Immunosuppressive Drugs: An Update
2007
Multistate Point-Prevalence Survey of Health Care–Associated Infections
2014 Standout
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease
2018
Apixaban, an oral, direct factor X a inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects
2012
Evidence-Based Surgical Care and the Evolution of Fast-Track Surgery
2008 Standout
Molecular imprinting: perspectives and applications
2016 Standout
Works of Mike Ufer being referenced
Voluntary Consumption of Amphetamine, Cocaine, Ethanol and Morphine by Rats as Influenced by a Preceding Period of Forced Drug Intake and Clozapine
1999
Determination of ( R )‐ and ( S )‐phenprocoumon in human plasma by enantioselective liquid chromatography/electrospray ionisation tandem mass spectrometry
2004
Patterns and prevalence of antidepressant drug use in the German state of Baden‐Wuerttemberg: a prescription‐based analysis
2007
Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development
2010
Identification of cytochromes P 450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro
2004
CYP3A5 Genotype Markedly Influences the Pharmacokinetics of Tacrolimus and Sirolimus in Kidney Transplant Recipients
2006
Quantification of cortisol and 6 beta-hydroxycortisol in human urine by LC-MS/MS, and gender-specific evaluation of the metabolic ratio as biomarker of CYP3A activity
2009
Antimicrobial drug use in hospitalised paediatric patients: a cross-national comparison between Germany and Croatia
2005
Paediatric adverse drug reactions reported in Sweden from 1987 to 2001
2005
Amantadine, a N-Methyl-d-Aspartate Receptor Antagonist, Does Not Enhance Postoperative Analgesia in Women Undergoing Abdominal Hysterectomy
2001
Adverse drug reactions and off‐label prescribing for paediatric outpatients: a one‐year survey of spontaneous reports in Sweden
2003
Comparative Pharmacokinetics of Vitamin K Antagonists
2005
Genetic polymorphisms of cytochrome P450 2C9 causing reduced phenprocoumon (S)-7-hydroxylationin vitroandin vivo
2004
Stereospecific pharmacokinetic characterisation of phenprocoumon metabolites, and mass-spectrometric identification of two novel metabolites in human plasma and liver microsomes
2005
Determination of phenprocoumon, warfarin and their monohydroxylated metabolites in human plasma and urine by liquid chromatography–mass spectrometry after solid-phase extraction
2004
O1‐10‐06: Results From a First‐in‐Human Study with the Bace Inhibitor CNP520
2016
No benefit of 3,4-diaminopyridine in essential tremor: A placebo-controlled crossover study
2006
Additive Interaction of the Cannabinoid Receptor I Agonist Arachidonyl-2-chloroethylamide with Etomidate in a Sedation Model in Mice
2008
Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers
2003